A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Creating Healthcare Campus Master Plans That Allow Movement and Respite
Aspirus Health Celebrates Opening of Chippewa Falls Hospital and Clinic
AdventHealth to Open Aurora Highlands Medical Campus
The Future of Healthcare Facility Construction Projects
Arnprior Regional Health Upgrades Building Controls to Improve IEQ